Abstract
In the field of critical neurology, several acquired disorders have been described that result in intensive care weakness. The most common are an acquired myopathy due to the use of corticosteroids and neuromuscular blocking agents (CIM) or acute quadriplegic myopathy and a debilitating axonal sensorimotor polyneuropathy (CIP): it is difficult on the bedside to make an appropriate diagnosis for which an accurate medical history, neurophysiological studies and a muscle biopsy is often needed. In intensive care unit, electrodiagnostic tests are difficult to perform; therefore a clinician should pursue a muscle biopsy. Diagnostic algorithm remains a clinical decision, but in order to determine causes and treatments of these conditions, a muscle biopsy is often needed and affects management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stevens RD, Marshall SA, Cornblath DR et al (2009) A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med 37(10 Suppl):S299–S308
Batt J, dos Santos CC, Cameron JI et al (2013) Intensive care unit-acquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med 187:238–246
Fan E, Cheek F, Chlan L et al (2014) An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med 190:1437–1446
Mirzakhani H, Williams JN, Mello J et al (2013) Muscle weakness predicts pharyngeal dysfunction and symptomatic aspiration in long-term ventilated patients. Anesthesiology 119:389–397
Friedrich O, Reid MB, Van den Berghe G et al (2015) The sick and the weak: neuropathies/myopathies in the critically Ill. Physiol Rev 95:1025–1109
Hermans G, Van den Berghe G (2015) Clinical review: intensive care unit acquired weakness. Crit Care. doi:10.1186/s13054-015-0993-7
Rodi Z, Filipović T, Švigelj V et al (2009) Critical illness myopathy in patients with central nervous system disorders http://vestnik.szd.si/index.php/ZdravVest/article/view/357. Zdrav Vest 78:289–293
Latronico N, Fenzi F, Recupero D et al (1996) Critical illness myopathy and neuropathy. Lancet 347:1579–1582
Latronico N, Gosselink R (2015) A guided approach to diagnose severe muscle weakness in the intensive care unit. Rev Bras Ter Intensiva 27:199–201
Hermans G, Clerckx B, Vanhullebusch T et al (2012) Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve 45:18–25
Vanhoutte EK, Faber CG, van Nes SI et al (2012) Modifying the Medical Research Council grading system through Rasch analyses. Brain 135:1639–1649
Parry SM, Berney S, Granger CL et al (2015) A new two-tier strength assessment approach to the diagnosis of weakness in intensive care: an observational study. Crit Care. doi:10.1186/s13054-015-0780-5
Ali NA, O’Brien JM Jr, Hoffmann SP et al (2008) Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med 178:261–268
Rich MM, Bird SJ, Raps EC et al (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20:665–673
Goodman BP, Harper CM, Boon AJ (2009) Prolonged compound muscle action potential duration in critical illness myopathy. Muscle Nerve 40:1040–1042
Latronico N, Shehu I, Guarneri B (2009) Use of electrophysiologic testing. Crit Care Med 37(10 Suppl):S316–S320
Latronico N, Nattino G, Guarneri B et al (2014) Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res. doi: 10.12688/f1000research.3933.3
Tennila A, Salmi T, Pettila V et al (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26:1360–1363
Carpenter S, Karpati G (2001) Pathology of skeletal muscle. Oxford University Press, New York
Stibler H, Edstrom L, Ahlbeck K et al (2003) Electrophoretic determination of the myosin/actin ratio in the diagnosis of critical illness myopathy. Intensive Care Med 29:1515–1527
Showalter CJ, Engel AG (1997) Acute quadriplegic myopathy: analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 20:316–322
Pati S, Goodfellow JA, Iyadurai S et al (2008) Approach to critical illness polyneuropathy and myopathy. Postgrad Med J 84:354–360
Guarneri B, Bertolini G, Latronico N (2008) Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 79:838–841
Latronico N, Filosto M, Fagoni N et al (2013) Small nerve fiber pathology in critical illness. PLoS One. doi:10.1371/journal.pone.0075696
Zochodne DW, Bolton CF, Wells GA et al (1987) Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain 110:819–841
Danon MJ, Carpenter S (1991) Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 14:1131–1139
Puthucheary Z, Montgomery H, Moxham J et al (2010) Structure to function: muscle failure in critically ill patients. J Physiol 588:4641–4648
Tiao G, Hobler S, Wang JJ et al (1997) Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 99:163–168
Constantin D, McCullough J, Mahajan RP et al (2011) Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol 589:3883–3895
Bhattacharyya J, Thompson K, Sayeed MM (1991) Calcium-dependent and calcium-independent protease activities in skeletal muscle during sepsis. Circ Shock 35:117–122
Salviati L, Laverda AM, Zancan L et al (2000) Acute quadriplegic myopathy in a 17-month-old boy. J Child Neurol 15:63–66
Klaude M, Mori M, Tjader I et al (2012) Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. Clin Sci (Lond) 122:133–142
Hussain SN, Mofarrahi M, Sigala I et al (2010) Mechanical ventilation-induced diaphragm disuse in humans triggers autophagy. Am J Respir Crit Care Med 182:1377–1386
Vanhorebeek I, Gunst J, Derde S et al (2011) Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. J Clin Endocrinol Metab. doi:10.1210/jc.2010-2563
Rennie MJ (2009) Anabolic resistance in critically ill patients. Crit Care Med 37(10 Suppl):S398–S399
Peterson CM, Johannsen DL, Ravussin E (2012) Skeletal muscle mitochondria and aging: a review. J Aging Res. doi:10.1155/2012/194821
Reid MB, Moylan JS (2011) Beyond atrophy: redox mechanisms of muscle dysfunction in chronic inflammatory disease. J Physiol 589:2171–2179
Carre JE, Orban JC, Re L et al (2010) Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 182:745–751
Vanhorebeek I, Gunst J, Derde S et al (2012) Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients. J Clin Endocrinol Metab. doi:10.1210/jc.2011-1760
Rich MM, Teener JW, Raps EC et al (1996) Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 46:731–736
Lefaucheur JP, Nordine T, Rodriguez P et al (2006) Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 77:500–506
Haeseler G, Foadi N, Wiegand E et al (2008) Endotoxin reduces availability of voltage-gated human skeletal muscle sodium channels at depolarized membrane potentials. Crit Care Med 36:1239–1247
Novak KR, Nardelli P, Cope TC et al (2009) Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest 119:1150–1158
Fenzi F, Latronico N, Refatti N et al (2003) Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acta Neuropathol 106:75–82
Bloch SA, Lee JY, Syburra T et al (2015) Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs. Thorax 70:219–228
Finfer S, Chittock DR, Su SY et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
Reade MC, Finfer S (2014) Sedation and delirium in the intensive care unit. N Engl J Med 370:444–454
Burtin C, Clerckx B, Robbeets C et al (2009) Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med 37:2499–2505
Maffiuletti NA, Roig M, Karatzanos E et al (2013) Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review. BMC Med. doi:10.1186/1741-7015-11-137
Hermans G, Casaer MP, Clerckx B et al (2013) Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lancet Respir Med 1:621–629
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Meznaric, M., Angelini, C. (2016). Intensive Care Unit-Acquired Weakness. In: Angelini, C. (eds) Acquired Neuromuscular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-29514-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-29514-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29512-1
Online ISBN: 978-3-319-29514-5
eBook Packages: MedicineMedicine (R0)